StockTipsArenaBeta

BUY Marksans Pharma Limited — Vishnu Kant Upadhyay, Master Capital Services

BUYMarksans Pharma Limited
Marksans Pharma share price target & all analyst calls

byVishnu Kant Upadhyay, Master Capital ServicesHorizon: NA (inferred Swing (≤2wk))29 Sept 2026via Business Today

Entry₹344Inferred
Target₹380
Total upside +10.47% (call closed)
Stop loss₹312-9.30% risk
Exit₹3128 Oct 2026, 11:15 am
Stop-loss hit-9.30%
Follow Vishnu Kant Upadhyay for new calls(12% target hit, 115 closed calls)Get alertsWatch MARKSANS for new buy/sell callsGet alertsSee 282 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 8 Oct 2026
1 supporting2 neutral0 opposing
Supports the BUY call (1)

1 advisor has an active short-term BUY call on this stock

Advisor consensus · adjacent horizon·18 Aug · 2mo ago

Neutral / worth noting (2)

Marksans Pharma Opens SEBI-Mandated Window for Re-Lodging Physical Share Transfers

NewsGoogle News·17 Sept · 3w ago

(opens in new tab)

Marksans Pharma opens special window for re-lodgement of physical share transfer requests

NewsGoogle News·17 Sept · 3w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Marksans Pharma

All analyst calls on Marksans Pharma

More from Vishnu Kant Upadhyay, Master Capital Services

Every call and its outcome